Kendle International to Implement Logos Technologies ALPHADAS clinical trial solutions

The solutions are designed to help Kendle streamline its existing clinical data processes and are expected to provide significant cost savings.

By Editor on Dec 22, 2004

The solutions are designed to help Kendle streamline its existing clinical data processes and are expected to provide significant cost savings. Kendle selected ALPHADAS and Phase I STK to provide an additional competitive advantage and enable the company to deliver more effective Phase I solutions for its customers.

We look forward to building on our existing relationship with Kendle and to establishing a long lasting client partnership, said Giles Wilson, Business Development Director of Logos Technologies. We are confident that the implementation will meet Kendle's expectation and provide many profitable and cost-saving benefits.

Logos's Clinical Data Management solution is designed to provide Kendle with a powerful and effective tool for collecting, monitoring and cleaning clinical trial data. Using Logos Technologies Phase I Site Tool Kit, Kendle hopes to increase efficiency by automating processes and rapidly reduce study setup times.

The ALPHADAS product from Logos Technologies will allow us to fully automate our Phase I activities globally, thereby creating efficiencies in the tracking and processing of clinical study data, said Missie Williams-Kaull, Vice President, Clinical Operations, of Kendle International's Phase I unit in Morgantown, West Virgina.